This inventor holds 4 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Wei Keat Lim: Innovator in Immunotherapy and Mitochondrial DNA Quality Control
Introduction
Wei Keat Lim is a prominent inventor based in Tarrytown, NY (US). He has made significant contributions to the fields of immunotherapy and mitochondrial DNA quality control. With a total of 4 patents to his name, Lim is recognized for his innovative approaches to cancer treatment and biological sample analysis.
Latest Patents
One of Wei Keat Lim's latest patents focuses on immunotherapy methods for patients whose tumors carry a high passenger gene mutation burden. This patent outlines methods for selecting cancer patients for immunotherapy by establishing a total passenger gene mutation burden from their tumors. It includes generating a background distribution for the mutational burden, normalizing the total burden against this distribution, and categorizing patients as immunotherapy responders based on their mutation burden. When identified as responders, patients may receive an immunotherapy regimen that activates or inhibits T cell receptors to enhance T cell activation and prolong immune cytolytic activities.
Another significant patent by Lim addresses mitochondrial DNA quality control. This patent provides methods for identifying unreliable biological samples that may be mislabeled or contaminated. It involves determining the heteroplasmy and homoplasmy of mitochondrial DNA present in biological samples, ensuring the integrity of the samples used in research and clinical settings.
Career Highlights
Wei Keat Lim is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to advance his research and innovations. His work at Regeneron has positioned him as a key player in the development of cutting-edge therapies and methodologies in the biomedical field.
Collaborations
Lim collaborates with notable colleagues, including Ruoyu Zhang and Gurinder Atwal. These partnerships enhance the research and development efforts at Regeneron, fostering an environment of innovation and discovery.
Conclusion
Wei Keat Lim's contributions to immunotherapy and mitochondrial DNA quality control exemplify the impact of innovative thinking in the medical field. His patents not only advance scientific knowledge but also hold the potential to improve patient outcomes in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile